Steglatro “Now Approved” Patient Website Jan 25, 2018Jan 22, 2018 Brand: Steglatro (ertugliflozin), Tablets Parent Company: Merck Drug Type: Prescription Drug Category: Endocrinology Campaign: now-approved Targeting: Patients, Caregivers Patient Website: https://www.steglatro.com/ HCP Website: https://www.merckconnect.com/steglatro/overview.html Single-page Single-page (mobile)